These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 21521379)
1. Hair regrowth with topical triiodothyronine ointment in patients with alopecia areata: a double-blind, randomized pilot clinical trial of efficacy. Nasiri S; Haghpanah V; Taheri E; Heshmat R; Larijani B; Saeedi M J Eur Acad Dermatol Venereol; 2012 May; 26(5):654-6. PubMed ID: 21521379 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. Tosti A; Iorizzo M; Botta GL; Milani M J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039 [TBL] [Abstract][Full Text] [Related]
3. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial. Vahlquist A; Törmä H; Carlsson B Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560 [TBL] [Abstract][Full Text] [Related]
4. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Olsen EA; Carson SC; Turney EA Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500 [TBL] [Abstract][Full Text] [Related]
5. Alopecia areata treated with topical minoxidil. Weiss VC; West DP; Fu TS; Robinson LA; Cook B; Cohen RL; Chambers DA Arch Dermatol; 1984 Apr; 120(4):457-63. PubMed ID: 6703751 [TBL] [Abstract][Full Text] [Related]
6. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata. Fransway AF; Muller SA Cutis; 1988 Jun; 41(6):431-5. PubMed ID: 3292159 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows. Faghihi G; Andalib F; Asilian A Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039 [TBL] [Abstract][Full Text] [Related]
8. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of severe alopecia areata with topical applications of cyclosporin A]. Mauduit G; Lenvers P; Barthélémy H; Thivolet J Ann Dermatol Venereol; 1987; 114(4):507-10. PubMed ID: 3619297 [TBL] [Abstract][Full Text] [Related]
10. Determination of the sildenafil effect on alopecia areata in childhood: An open-pilot comparison study. Sarifakioglu E; Degim IT; Gorpelioglu C J Dermatolog Treat; 2006; 17(4):235-7. PubMed ID: 16971319 [TBL] [Abstract][Full Text] [Related]
11. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial. Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of oral minoxidil in the treatment of alopecia areata. Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909 [TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503 [TBL] [Abstract][Full Text] [Related]
14. A trial of 1% minoxidil used topically for severe alopecia areata. Vestey JP; Savin JA Acta Derm Venereol; 1986; 66(2):179-80. PubMed ID: 2424249 [TBL] [Abstract][Full Text] [Related]
15. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study. Chua SH; Goh CL; Ang CB Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014 [TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016 [TBL] [Abstract][Full Text] [Related]
17. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Tang L; Cao L; Sundberg JP; Lui H; Shapiro J Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110 [TBL] [Abstract][Full Text] [Related]
18. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata. Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382 [TBL] [Abstract][Full Text] [Related]
19. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480 [TBL] [Abstract][Full Text] [Related]
20. 308-nm excimer laser for the treatment of alopecia areata. Al-Mutairi N Dermatol Surg; 2007 Dec; 33(12):1483-7. PubMed ID: 18076615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]